The Cytotoxic Effect of 64Cu/NOTA-Terpyridine Platinum Conjugate, as a Novel Chemoradiotherapy Agent †
Abstract
:Supplementary Materials
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Khosravifarsani, M.; Ait-Mohand, S.; Paquette, B.; Sanche, L.; Guérin, B. The Cytotoxic Effect of 64Cu/NOTA-Terpyridine Platinum Conjugate, as a Novel Chemoradiotherapy Agent. Med. Sci. Forum 2021, 3, 7. https://doi.org/10.3390/IECC2021-09220
Khosravifarsani M, Ait-Mohand S, Paquette B, Sanche L, Guérin B. The Cytotoxic Effect of 64Cu/NOTA-Terpyridine Platinum Conjugate, as a Novel Chemoradiotherapy Agent. Medical Sciences Forum. 2021; 3(1):7. https://doi.org/10.3390/IECC2021-09220
Chicago/Turabian StyleKhosravifarsani, Meysam, Samia Ait-Mohand, Benoit Paquette, Léon Sanche, and Brigitte Guérin. 2021. "The Cytotoxic Effect of 64Cu/NOTA-Terpyridine Platinum Conjugate, as a Novel Chemoradiotherapy Agent" Medical Sciences Forum 3, no. 1: 7. https://doi.org/10.3390/IECC2021-09220
APA StyleKhosravifarsani, M., Ait-Mohand, S., Paquette, B., Sanche, L., & Guérin, B. (2021). The Cytotoxic Effect of 64Cu/NOTA-Terpyridine Platinum Conjugate, as a Novel Chemoradiotherapy Agent. Medical Sciences Forum, 3(1), 7. https://doi.org/10.3390/IECC2021-09220